Pure Global

System Accuracy of BGM GL60 - Trial NCT06037486

Access comprehensive clinical trial information for NCT06037486 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut fur Diabetes Karlsburg GmbH and is currently Completed. The study focuses on Diabetes Mellitus. Target enrollment is 101 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06037486
Completed
diagnostic test
Trial Details
ClinicalTrials.gov • NCT06037486
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
System Accuracy of BGM GL60
Evaluierung Der Systemgenauigkeit Des Blutglucosemonitoring Systems GL60 gemäß DIN EN ISO 15197:2015

Study Focus

Diabetes Mellitus

Glucometer Test

Interventional

diagnostic test

Sponsor & Location

Institut fur Diabetes Karlsburg GmbH

Karlsburg, Germany

Timeline & Enrollment

N/A

Oct 17, 2022

Nov 15, 2022

101 participants

Primary Outcome

Analysis of system accuracy based on DIN EN ISO 15197

Summary

This study assesses the system accuracy a blood glucose monitoring systems pursuant to ISO
 15197

ICD-10 Classifications

Diabetes mellitus
Unspecified diabetes mellitus
Other specified diabetes mellitus
Unspecified diabetes mellitus without complications
Unspecified diabetes mellitus with unspecified complications

Data Source

ClinicalTrials.gov

NCT06037486

Non-Device Trial